Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Ventana Unveils the Latest in Digital Pathology and Lab Workflow Solutions

Published: Sunday, October 14, 2012
Last Updated: Sunday, October 14, 2012
Bookmark and Share
Ventana Medical Systems, Inc. (Ventana) has unveiled the latest versions of its Virtuoso digital pathology image and workflow management software and VANTAGE workflow solution for histology lab specimen tracking. IAP 2012, one of the premier pathology conferences worldwide, takes place September 30 through October 5, 2012 in Cape Town, South Africa.

Ventana Medical Systems, Inc. (Ventana) has unveiled the latest versions of its Virtuoso digital pathology image and workflow management software and VANTAGE workflow solution for histology lab specimen tracking.

"I am thrilled to be presenting our latest products," explained Steve Burnell, PhD, Lifecycle Leader for Digital Pathology and Workflow for Ventana Medical Systems, Inc. "The global adoption of digital pathology and lab workflow solutions is gaining momentum, driven by benefits to laboratory efficiency and productivity, as well as improvements in patient care. As the established innovation leader in these areas, the Ventana launch of Virtuoso 5.3 – with a user interface now available in 21 languages – and VANTAGE 2.2 – with improved integration, underscores our commitment to pathologists, laboratory staff and patients to deliver the most innovative products in the industry."

Virtuoso web-based software orchestrates the digital slide workflow from the moment the slide is scanned until the slide image is viewed and the case results reported. With Virtuoso 5.3, Ventana has expanded the user interface to 21 languages, making it easy for international customers to adopt this new technology.

"I am pleased to see Ventana continue to take a leadership role in digital pathology with the latest offering of its Virtuoso software released in multiple languages. This is a reflection of the strong interest in digital pathology from labs across the globe. Virtuoso not only increases the effectiveness of labs like mine working with cases from Mexico and the US, but also enables us to improve patient care." Jesus Ellin – Yuma Regional Medical, Yuma, AZ USA.

The market-leading VANTAGE workflow solution automates, streamlines, and integrates lab work and information flow to provide increased productivity and patient safety gains. The VANTAGE 2.2 release introduces increased Laboratory Information System (LIS) integration capabilities, touchscreen workflow enhancements and case assembly improvements in response to global customers' needs. Through its integration with Virtuoso software, the VANTAGE workflow solution enables pathologists and lab managers to track the progress of a slide from preparation to digitization along with other critical slide information, giving a lab unprecedented visibility into its processes and tools to optimize lab workflow.

Ventana's newest scanner, the VENTANA iScan HT slide scanner, will also be showcased at IAP 2012. The VENTANA iScan HT is the most powerful scanner in anatomic pathology today, enabling pathologists and lab managers to optimize their digital pathology workflow with efficiency, convenience, speed, throughput and reliability for unprecedented results. The VENTANA iScan HT slide scanner is ideal for high throughput and high volume applications. It complements the VENTANA comprehensive suite of digital pathology solutions which also includes the iScan Coreo slide scanner, Virtuoso software, and the most comprehensive portfolio of research use only (RUO), CE-IVD and FDA-cleared 510(k) image analysis algorithms available.

"Since the acquisition of BioImagene two years ago, Roche and Ventana have invested heavily in Digital Pathology, bringing a wide range of innovative new products to the market. We believe that by driving the rapid adoption of digital pathology and improved workflow globally, we will help improve patient care. Our customers can expect sustained and unparalleled innovation from Ventana in the future," says Mara G. Aspinall, President of Ventana Medical Systems, Inc.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Find U.S. Breast Milk is Glyphosate Free
Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother’s breast milk.
Peering into the Vapors
Research suggests that e-cigarettes are much less harmful than previous studies have indicated.
New Technique for Mining Health-conferring Soy Compounds
A new procedure devised by U.S. Department of Agriculture (USDA) scientists to extract lunasin from soybean seeds could expedite further studies of this peptide for its cancer-fighting potential and other health benefits.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!